172 related articles for article (PubMed ID: 9020286)
1. Treatment of metastatic carcinoma of the prostate.
Goethuys H; Baert L; Van Poppel H; Lieskovsky G; Brady LW; Petrovich Z
Am J Clin Oncol; 1997 Feb; 20(1):40-5. PubMed ID: 9020286
[TBL] [Abstract][Full Text] [Related]
2. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.
Seidenfeld J; Samson DJ; Aronson N; Albertson PC; Bayoumi AM; Bennett C; Brown A; Garber A; Gere M; Hasselblad V; Wilt T; Ziegler K
Evid Rep Technol Assess (Summ); 1999 May; (4):i-x, 1-246, I1-36, passim. PubMed ID: 11098244
[TBL] [Abstract][Full Text] [Related]
3. [Keyrole of endocrinology in the victory against prostate cancer].
Labrie F
Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238
[TBL] [Abstract][Full Text] [Related]
4. Treatment options in androgen-independent prostate cancer.
Lara PN; Meyers FJ
Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of androgen suppression therapies in advanced prostate cancer.
Bayoumi AM; Brown AD; Garber AM
J Natl Cancer Inst; 2000 Nov; 92(21):1731-9. PubMed ID: 11058616
[TBL] [Abstract][Full Text] [Related]
6. First-line treatment of metastatic prostate cancer. Androgen suppression for symptomatic disease.
Prescrire Int; 2013 Feb; 22(135):48-51. PubMed ID: 23444510
[TBL] [Abstract][Full Text] [Related]
7. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
[TBL] [Abstract][Full Text] [Related]
8. [Total androgen blockade--concept, theory, method and clinical application].
Ozono S; Hirao Y
Nihon Rinsho; 1998 Aug; 56(8):2129-34. PubMed ID: 9750521
[TBL] [Abstract][Full Text] [Related]
9. Hormone therapy of prostatic bone metastases.
Huben RP
Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
[TBL] [Abstract][Full Text] [Related]
10. Hormonal therapy of prostate cancer.
Debruyne F
Semin Urol Oncol; 2002 Aug; 20(3 Suppl 1):4-9. PubMed ID: 12198632
[TBL] [Abstract][Full Text] [Related]
11. Combined androgen blockade: the gold standard for metastatic prostate cancer.
McLeod DG; Crawford ED; DeAntoni EP
Eur Urol; 1997; 32 Suppl 3():70-7. PubMed ID: 9267789
[TBL] [Abstract][Full Text] [Related]
12. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
13. Medical versus surgical androgen suppression therapy for prostate cancer: a 10-year longitudinal cost study.
Mariani AJ; Glover M; Arita S
J Urol; 2001 Jan; 165(1):104-7. PubMed ID: 11125375
[TBL] [Abstract][Full Text] [Related]
14. [Cost-utility analysis of androgen ablation therapy in metastatic prostate cancer].
Fujikawa K; Awakura Y; Okabe T; Watanabe R; Nishimura S
Nihon Hinyokika Gakkai Zasshi; 2003 May; 94(4):503-11; discussion 511-2. PubMed ID: 12795165
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
Chang A; Yeap B; Davis T; Blum R; Hahn R; Khanna O; Fisher H; Rosenthal J; Witte R; Schinella R; Trump D
J Clin Oncol; 1996 Aug; 14(8):2250-7. PubMed ID: 8708714
[TBL] [Abstract][Full Text] [Related]
16. [Hormonal therapy for prostatic cancer--state of the art].
Miyakita H
Nihon Rinsho; 2005 Feb; 63(2):305-8. PubMed ID: 15714983
[TBL] [Abstract][Full Text] [Related]
17. Secondary hormonal therapy.
Smith DC
Semin Urol Oncol; 1997 Feb; 15(1):3-12. PubMed ID: 9050134
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in endocrine treatment of prostate cancer.
Vogelzang NJ; Kennealey GT
Cancer; 1992 Aug; 70(4 Suppl):966-76. PubMed ID: 1386283
[TBL] [Abstract][Full Text] [Related]
19. The changing face of hormonal therapy for prostate cancer.
Seruga B; Tannock IF
Ann Oncol; 2008 Sep; 19 Suppl 7():vii79-85. PubMed ID: 18790984
[No Abstract] [Full Text] [Related]
20. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
